guest ::
| Home > Publications Database > A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment. > print |
| Home > Publications Database > A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment. > print |
| 001 | 137097 | ||
| 005 | 20240321220204.0 | ||
| 024 | 7 | _ | |a 10.1093/brain/awt263 |2 doi |
| 024 | 7 | _ | |a pmid:24163364 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC4125626 |2 pmc |
| 024 | 7 | _ | |a 0006-8950 |2 ISSN |
| 024 | 7 | _ | |a 1460-2156 |2 ISSN |
| 024 | 7 | _ | |a altmetric:1862958 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-03419 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a del Campo, Natalia |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
| 245 | _ | _ | |a A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment. |
| 260 | _ | _ | |a Oxford |c 2013 |b Oxford Univ. Press |
| 264 | _ | 1 | |3 online |2 Crossref |b Oxford University Press (OUP) |c 2013-10-25 |
| 264 | _ | 1 | |3 print |2 Crossref |b Oxford University Press (OUP) |c 2013-11-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1585563344_22217 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Through the combined use of (18)F-fallypride positron emission tomography and magnetic resonance imaging this study examined the neural mechanisms underlying the attentional deficits associated with attention deficit/hyperactivity disorder and their potential reversal with a single therapeutic dose of methylphenidate. Sixteen adult patients with attention deficit/hyperactivity disorder and 16 matched healthy control subjects were positron emission tomography and magnetic resonance imaging scanned and tested on a computerized sustained attention task after oral methylphenidate (0.5 mg/kg) and placebo administration in a within-subject, double-blind, cross-over design. Although patients with attention deficit/hyperactivity disorder as a group showed significant attentional deficits and reduced grey matter volume in fronto-striato-cerebellar and limbic networks, they had equivalent D2/D3 receptor availability and equivalent increases in endogenous dopamine after methylphenidate treatment to that observed in healthy control subjects. However, poor attentional performers drawn from both the attention deficit/hyperactivity disorder and the control groups had significantly reduced left caudate dopamine activity. Methylphenidate significantly increased dopamine levels in all nigro-striatal regions, thereby normalizing dopamine levels in the left caudate in low performers. Behaviourally, methylphenidate improved sustained attention in a baseline performance-dependent manner, irrespective of diagnosis. This finding was accompanied by an equally performance-dependent effect of the drug on dopamine release in the midbrain, whereby low performers showed reduced dopamine release in this region. Collectively, these findings support a dimensional model of attentional deficits and underlying nigro-striatal dopaminergic mechanisms of attention deficit/hyperactivity disorder that extends into the healthy population. Moreover, they confer midbrain dopamine autoreceptors a hitherto neglected role in the therapeutic effects of oral methylphenidate in attention deficit/hyperactivity disorder. The absence of significant case-control differences in D2/D3 receptor availability (despite the observed relationships between dopamine activity and attention) suggests that dopamine dysregulation per se is unlikely to be the primary cause underlying attention deficit/hyperactivity disorder pathology in adults. This conclusion is reinforced by evidence of neuroanatomical changes in the same set of patients with attention deficit/hyperactivity disorder. |
| 536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Benzamides |2 NLM Chemicals |
| 650 | _ | 7 | |a Dopamine Uptake Inhibitors |2 NLM Chemicals |
| 650 | _ | 7 | |a Radiopharmaceuticals |2 NLM Chemicals |
| 650 | _ | 7 | |a Fluorodeoxyglucose F18 |0 0Z5B2CJX4D |2 NLM Chemicals |
| 650 | _ | 7 | |a Methylphenidate |0 207ZZ9QZ49 |2 NLM Chemicals |
| 650 | _ | 7 | |a fallypride |0 G9FWZ369GX |2 NLM Chemicals |
| 650 | _ | 2 | |a Adult |2 MeSH |
| 650 | _ | 2 | |a Attention Deficit Disorder with Hyperactivity: drug therapy |2 MeSH |
| 650 | _ | 2 | |a Attention Deficit Disorder with Hyperactivity: metabolism |2 MeSH |
| 650 | _ | 2 | |a Attention Deficit Disorder with Hyperactivity: pathology |2 MeSH |
| 650 | _ | 2 | |a Attention Deficit Disorder with Hyperactivity: physiopathology |2 MeSH |
| 650 | _ | 2 | |a Benzamides |2 MeSH |
| 650 | _ | 2 | |a Corpus Striatum: drug effects |2 MeSH |
| 650 | _ | 2 | |a Corpus Striatum: metabolism |2 MeSH |
| 650 | _ | 2 | |a Corpus Striatum: pathology |2 MeSH |
| 650 | _ | 2 | |a Corpus Striatum: physiopathology |2 MeSH |
| 650 | _ | 2 | |a Cross-Over Studies |2 MeSH |
| 650 | _ | 2 | |a Dopamine Uptake Inhibitors: administration & dosage |2 MeSH |
| 650 | _ | 2 | |a Dopamine Uptake Inhibitors: pharmacology |2 MeSH |
| 650 | _ | 2 | |a Double-Blind Method |2 MeSH |
| 650 | _ | 2 | |a Fluorodeoxyglucose F18 |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Magnetic Resonance Imaging: instrumentation |2 MeSH |
| 650 | _ | 2 | |a Magnetic Resonance Imaging: methods |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Mesencephalon: drug effects |2 MeSH |
| 650 | _ | 2 | |a Mesencephalon: metabolism |2 MeSH |
| 650 | _ | 2 | |a Mesencephalon: pathology |2 MeSH |
| 650 | _ | 2 | |a Mesencephalon: physiopathology |2 MeSH |
| 650 | _ | 2 | |a Methylphenidate: administration & dosage |2 MeSH |
| 650 | _ | 2 | |a Methylphenidate: pharmacology |2 MeSH |
| 650 | _ | 2 | |a Multimodal Imaging: instrumentation |2 MeSH |
| 650 | _ | 2 | |a Multimodal Imaging: methods |2 MeSH |
| 650 | _ | 2 | |a Positron-Emission Tomography: instrumentation |2 MeSH |
| 650 | _ | 2 | |a Positron-Emission Tomography: methods |2 MeSH |
| 650 | _ | 2 | |a Psychiatric Status Rating Scales |2 MeSH |
| 650 | _ | 2 | |a Radiopharmaceuticals |2 MeSH |
| 650 | _ | 2 | |a Young Adult |2 MeSH |
| 700 | 1 | _ | |a Fryer, Tim D |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Hong, Young T |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Smith, Rob |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Brichard, Laurent |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Acosta-Cabronero, Julio |0 P:(DE-2719)2810751 |b 5 |u dzne |
| 700 | 1 | _ | |a Chamberlain, Samuel R |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Tait, Roger |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Izquierdo, David |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Regenthal, Ralf |0 P:(DE-HGF)0 |b 9 |
| 700 | 1 | _ | |a Dowson, Jonathan |0 P:(DE-HGF)0 |b 10 |
| 700 | 1 | _ | |a Suckling, John |0 P:(DE-HGF)0 |b 11 |
| 700 | 1 | _ | |a Baron, Jean-Claude |0 P:(DE-HGF)0 |b 12 |
| 700 | 1 | _ | |a Aigbirhio, Franklin I |0 P:(DE-HGF)0 |b 13 |
| 700 | 1 | _ | |a Robbins, Trevor W |0 P:(DE-HGF)0 |b 14 |
| 700 | 1 | _ | |a Sahakian, Barbara J |0 P:(DE-HGF)0 |b 15 |
| 700 | 1 | _ | |a Müller, Ulrich |0 P:(DE-HGF)0 |b 16 |
| 773 | 1 | 8 | |a 10.1093/brain/awt263 |b : Oxford University Press (OUP), 2013-10-25 |n 11 |p 3252-3270 |3 journal-article |2 Crossref |t Brain |v 136 |y 2013 |x 1460-2156 |
| 773 | _ | _ | |a 10.1093/brain/awt263 |g Vol. 136, no. Pt 11, p. 3252 - 3270 |0 PERI:(DE-600)1474117-9 |n 11 |q 136:Pt 11<3252 - 3270 |p 3252-3270 |t Brain |v 136 |y 2013 |x 1460-2156 |
| 856 | 7 | _ | |2 Pubmed Central |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125626 |
| 909 | C | O | |o oai:pub.dzne.de:137097 |p VDB |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 5 |6 P:(DE-2719)2810751 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |2 G:(DE-HGF)POF3-300 |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2013 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b BRAIN : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b BRAIN : 2017 |
| 920 | 1 | _ | |0 I:(DE-2719)1310001 |k AG Nestor |l Cognitive Neurology and Neurodegeneration |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1310001 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |a 10.1007/s00259-008-0969-9 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00259-008-0969-9 |
| 999 | C | 5 | |a 10.1001/archpsyc.55.4.362 |9 -- missing cx lookup -- |2 Crossref |o 10.1001/archpsyc.55.4.362 |
| 999 | C | 5 | |a 10.1016/j.neuroimage.2005.02.018 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neuroimage.2005.02.018 |
| 999 | C | 5 | |a 10.1037/0033-2909.121.1.65 |9 -- missing cx lookup -- |2 Crossref |o 10.1037/0033-2909.121.1.65 |
| 999 | C | 5 | |a 10.1076/neur.9.1.70.14374 |9 -- missing cx lookup -- |2 Crossref |o 10.1076/neur.9.1.70.14374 |
| 999 | C | 5 | |a 10.1176/appi.ajp.157.5.816 |9 -- missing cx lookup -- |2 Crossref |o 10.1176/appi.ajp.157.5.816 |
| 999 | C | 5 | |a 10.1523/JNEUROSCI.4370-06.2007 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.4370-06.2007 |
| 999 | C | 5 | |a 10.1523/JNEUROSCI.20-10-03874.2000 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.20-10-03874.2000 |
| 999 | C | 5 | |a 10.1109/42.750253 |9 -- missing cx lookup -- |2 Crossref |o 10.1109/42.750253 |
| 999 | C | 5 | |a 10.1126/science.1257777 |9 -- missing cx lookup -- |2 Crossref |o 10.1126/science.1257777 |
| 999 | C | 5 | |a 10.1016/j.biopsych.2005.01.034 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.biopsych.2005.01.034 |
| 999 | C | 5 | |a 10.2165/11539440-000000000-00000 |9 -- missing cx lookup -- |2 Crossref |o 10.2165/11539440-000000000-00000 |
| 999 | C | 5 | |a 10.1016/S0025-6196(11)64618-1 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0025-6196(11)64618-1 |
| 999 | C | 5 | |a 10.1016/j.biopsych.2007.03.003 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.biopsych.2007.03.003 |
| 999 | C | 5 | |a 10.1016/j.biopsych.2006.07.020 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.biopsych.2006.07.020 |
| 999 | C | 5 | |a 10.1523/JNEUROSCI.3266-08.2009 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.3266-08.2009 |
| 999 | C | 5 | |a 10.1098/rsta.2004.1468 |9 -- missing cx lookup -- |2 Crossref |o 10.1098/rsta.2004.1468 |
| 999 | C | 5 | |a 10.1016/0028-3932(96)00029-2 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/0028-3932(96)00029-2 |
| 999 | C | 5 | |a 10.1073/pnas.1009396107 |9 -- missing cx lookup -- |2 Crossref |o 10.1073/pnas.1009396107 |
| 999 | C | 5 | |a 10.1002/syn.20506 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/syn.20506 |
| 999 | C | 5 | |a 10.1523/JNEUROSCI.11-07-01907.1991 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.11-07-01907.1991 |
| 999 | C | 5 | |a 10.1016/j.biopsych.2011.02.036 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.biopsych.2011.02.036 |
| 999 | C | 5 | |a 10.1007/7854_2012_200 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/7854_2012_200 |
| 999 | C | 5 | |a 10.1016/j.neuroimage.2010.11.071 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neuroimage.2010.11.071 |
| 999 | C | 5 | |y 1958 |2 Crossref |o Dews 1958 |
| 999 | C | 5 | |a 10.1073/pnas.85.14.5274 |9 -- missing cx lookup -- |2 Crossref |o 10.1073/pnas.85.14.5274 |
| 999 | C | 5 | |a 10.1016/S0006-3223(00)01038-6 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0006-3223(00)01038-6 |
| 999 | C | 5 | |a 10.1016/S0893-133X(99)00079-2 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0893-133X(99)00079-2 |
| 999 | C | 5 | |a 10.1007/s002130050284 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s002130050284 |
| 999 | C | 5 | |a 10.1523/JNEUROSCI.18-15-05901.1998 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.18-15-05901.1998 |
| 999 | C | 5 | |y 1999 |2 Crossref |o Ernst 1999 |
| 999 | C | 5 | |a 10.4088/JCP.08m04902pur |9 -- missing cx lookup -- |2 Crossref |o 10.4088/JCP.08m04902pur |
| 999 | C | 5 | |a 10.1007/s00213-010-1823-x |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00213-010-1823-x |
| 999 | C | 5 | |a 10.1016/j.bandc.2007.10.002 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.bandc.2007.10.002 |
| 999 | C | 5 | |y 2013 |2 Crossref |o Gau 2013 |
| 999 | C | 5 | |a 10.3758/CABN.5.2.212 |9 -- missing cx lookup -- |2 Crossref |o 10.3758/CABN.5.2.212 |
| 999 | C | 5 | |a 10.1038/npp.2012.117 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/npp.2012.117 |
| 999 | C | 5 | |a 10.1016/S0074-7742(05)63001-2 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0074-7742(05)63001-2 |
| 999 | C | 5 | |a 10.1016/0306-4522(91)90196-U |9 -- missing cx lookup -- |2 Crossref |o 10.1016/0306-4522(91)90196-U |
| 999 | C | 5 | |y 2001 |2 Crossref |t Psychostimulant actions on dopamine and limbic system function: relevance to the pathophysiology and treatment of ADHD |o Grace Psychostimulant actions on dopamine and limbic system function: relevance to the pathophysiology and treatment of ADHD 2001 |
| 999 | C | 5 | |a 10.1006/nimg.1997.0303 |9 -- missing cx lookup -- |2 Crossref |o 10.1006/nimg.1997.0303 |
| 999 | C | 5 | |a 10.1016/j.jchemneu.2003.10.003 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.jchemneu.2003.10.003 |
| 999 | C | 5 | |a 10.1523/JNEUROSCI.20-06-02369.2000 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.20-06-02369.2000 |
| 999 | C | 5 | |a 10.1016/S0306-4522(99)00575-8 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0306-4522(99)00575-8 |
| 999 | C | 5 | |a 10.1016/j.biopsych.2004.11.009 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.biopsych.2004.11.009 |
| 999 | C | 5 | |a 10.1111/j.1460-9568.2004.03310.x |9 -- missing cx lookup -- |2 Crossref |o 10.1111/j.1460-9568.2004.03310.x |
| 999 | C | 5 | |a 10.1001/archgenpsychiatry.2010.10 |9 -- missing cx lookup -- |2 Crossref |o 10.1001/archgenpsychiatry.2010.10 |
| 999 | C | 5 | |a 10.1017/S0033291704002892 |9 -- missing cx lookup -- |2 Crossref |o 10.1017/S0033291704002892 |
| 999 | C | 5 | |a 10.1073/pnas.95.13.7731 |9 -- missing cx lookup -- |2 Crossref |o 10.1073/pnas.95.13.7731 |
| 999 | C | 5 | |a 10.1097/00001756-199711100-00032 |9 -- missing cx lookup -- |2 Crossref |o 10.1097/00001756-199711100-00032 |
| 999 | C | 5 | |a 10.1109/23.34585 |9 -- missing cx lookup -- |2 Crossref |o 10.1109/23.34585 |
| 999 | C | 5 | |a 10.1007/BF02257400 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/BF02257400 |
| 999 | C | 5 | |a 10.1385/NMM:8:4:461 |9 -- missing cx lookup -- |2 Crossref |o 10.1385/NMM:8:4:461 |
| 999 | C | 5 | |a 10.1097/00006231-199808000-00009 |9 -- missing cx lookup -- |2 Crossref |o 10.1097/00006231-199808000-00009 |
| 999 | C | 5 | |a 10.1097/00004647-200003000-00001 |9 -- missing cx lookup -- |2 Crossref |o 10.1097/00004647-200003000-00001 |
| 999 | C | 5 | |a 10.1162/089892903770007416 |9 -- missing cx lookup -- |2 Crossref |o 10.1162/089892903770007416 |
| 999 | C | 5 | |a 10.1016/j.neubiorev.2003.08.009 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neubiorev.2003.08.009 |
| 999 | C | 5 | |a 10.1016/S0893-133X(02)00366-4 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0893-133X(02)00366-4 |
| 999 | C | 5 | |a 10.1016/S1364-6613(00)01769-1 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S1364-6613(00)01769-1 |
| 999 | C | 5 | |a 10.1016/j.neuropsychologia.2009.01.016 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neuropsychologia.2009.01.016 |
| 999 | C | 5 | |a 10.1097/01.WCB.0000048520.34839.1A |9 -- missing cx lookup -- |2 Crossref |o 10.1097/01.WCB.0000048520.34839.1A |
| 999 | C | 5 | |a 10.1006/nimg.2000.0610 |9 -- missing cx lookup -- |2 Crossref |o 10.1006/nimg.2000.0610 |
| 999 | C | 5 | |a 10.1073/pnas.0931309100 |9 -- missing cx lookup -- |2 Crossref |o 10.1073/pnas.0931309100 |
| 999 | C | 5 | |a 10.1097/00004647-200109000-00002 |9 -- missing cx lookup -- |2 Crossref |o 10.1097/00004647-200109000-00002 |
| 999 | C | 5 | |y 1972 |2 Crossref |t A primer of signal detection theory |o McNicol A primer of signal detection theory 1972 |
| 999 | C | 5 | |a 10.1111/j.1469-7610.2004.00221.x |9 -- missing cx lookup -- |2 Crossref |o 10.1111/j.1469-7610.2004.00221.x |
| 999 | C | 5 | |a 10.1523/JNEUROSCI.20-06-j0004.2000 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.20-06-j0004.2000 |
| 999 | C | 5 | |a 10.1016/0024-3205(92)90479-9 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/0024-3205(92)90479-9 |
| 999 | C | 5 | |y 1997 |2 Crossref |o Mercuri 1997 |
| 999 | C | 5 | |a 10.1176/appi.ajp.2011.11020281 |9 -- missing cx lookup -- |2 Crossref |o 10.1176/appi.ajp.2011.11020281 |
| 999 | C | 5 | |a 10.1007/BF00431690 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/BF00431690 |
| 999 | C | 5 | |y 1982 |2 Crossref |t National Adult Reading Test (NART): test manual |o Nelson National Adult Reading Test (NART): test manual 1982 |
| 999 | C | 5 | |a 10.1037/0033-2909.126.2.220 |9 -- missing cx lookup -- |2 Crossref |o 10.1037/0033-2909.126.2.220 |
| 999 | C | 5 | |a 10.1016/j.biopsych.2004.11.011 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.biopsych.2004.11.011 |
| 999 | C | 5 | |a 10.1007/BF00427335 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/BF00427335 |
| 999 | C | 5 | |a 10.1586/14737175.7.10.1337 |9 -- missing cx lookup -- |2 Crossref |o 10.1586/14737175.7.10.1337 |
| 999 | C | 5 | |a 10.1126/science.341313 |9 -- missing cx lookup -- |2 Crossref |o 10.1126/science.341313 |
| 999 | C | 5 | |a 10.1001/archpsyc.1980.01780210091010 |9 -- missing cx lookup -- |2 Crossref |o 10.1001/archpsyc.1980.01780210091010 |
| 999 | C | 5 | |a 10.1038/sj.npp.1300916 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/sj.npp.1300916 |
| 999 | C | 5 | |a 10.1176/ajp.2006.163.9.1639 |9 -- missing cx lookup -- |2 Crossref |o 10.1176/ajp.2006.163.9.1639 |
| 999 | C | 5 | |y 2010 |2 Crossref |t Dopamine handbook |o Robbins Dopamine handbook 2010 |
| 999 | C | 5 | |a 10.1016/0028-3908(79)90157-6 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/0028-3908(79)90157-6 |
| 999 | C | 5 | |a 10.1007/PL00005494 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/PL00005494 |
| 999 | C | 5 | |a 10.1503/jpn.090044 |9 -- missing cx lookup -- |2 Crossref |o 10.1503/jpn.090044 |
| 999 | C | 5 | |a 10.1016/j.neuroimage.2004.11.031 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neuroimage.2004.11.031 |
| 999 | C | 5 | |y 1998 |2 Crossref |o Rousset 1998 |
| 999 | C | 5 | |a 10.1038/4501157a |9 -- missing cx lookup -- |2 Crossref |o 10.1038/4501157a |
| 999 | C | 5 | |a 10.1016/0306-9877(77)90065-2 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/0306-9877(77)90065-2 |
| 999 | C | 5 | |a 10.1016/0168-0102(88)90030-2 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/0168-0102(88)90030-2 |
| 999 | C | 5 | |a 10.1177/08830738020170122001 |9 -- missing cx lookup -- |2 Crossref |o 10.1177/08830738020170122001 |
| 999 | C | 5 | |a 10.1038/sj.mp.4000421 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/sj.mp.4000421 |
| 999 | C | 5 | |a 10.1016/j.biopsych.2004.11.019 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.biopsych.2004.11.019 |
| 999 | C | 5 | |a 10.1016/S0006-3223(97)00448-4 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0006-3223(97)00448-4 |
| 999 | C | 5 | |a 10.1523/JNEUROSCI.14-01-00088.1994 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.14-01-00088.1994 |
| 999 | C | 5 | |a 10.4088/JCP.09m05305whi |9 -- missing cx lookup -- |2 Crossref |o 10.4088/JCP.09m05305whi |
| 999 | C | 5 | |a 10.1038/sj.npp.1300534 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/sj.npp.1300534 |
| 999 | C | 5 | |a 10.1192/bjp.bp.107.048827 |9 -- missing cx lookup -- |2 Crossref |o 10.1192/bjp.bp.107.048827 |
| 999 | C | 5 | |a 10.1002/syn.20734 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/syn.20734 |
| 999 | C | 5 | |a 10.1037/0033-2909.95.3.387 |9 -- missing cx lookup -- |2 Crossref |o 10.1037/0033-2909.95.3.387 |
| 999 | C | 5 | |a 10.1016/S0002-7138(09)60604-X |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0002-7138(09)60604-X |
| 999 | C | 5 | |a 10.1016/S0166-4328(97)00175-7 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S0166-4328(97)00175-7 |
| 999 | C | 5 | |a 10.1016/j.biopsych.2006.07.032 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.biopsych.2006.07.032 |
| 999 | C | 5 | |a 10.1111/j.1469-8986.1984.tb00247.x |9 -- missing cx lookup -- |2 Crossref |o 10.1111/j.1469-8986.1984.tb00247.x |
| 999 | C | 5 | |a 10.1007/s00213-005-0025-4 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00213-005-0025-4 |
| 999 | C | 5 | |a 10.1007/s00213-004-1993-5 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00213-004-1993-5 |
| 999 | C | 5 | |a 10.1007/s00213-003-1457-3 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00213-003-1457-3 |
| 999 | C | 5 | |a 10.1006/nimg.2001.0978 |9 -- missing cx lookup -- |2 Crossref |o 10.1006/nimg.2001.0978 |
| 999 | C | 5 | |a 10.1016/j.neuroimage.2006.10.013 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neuroimage.2006.10.013 |
| 999 | C | 5 | |a 10.1176/appi.ajp.163.3.359 |9 -- missing cx lookup -- |2 Crossref |o 10.1176/appi.ajp.163.3.359 |
| 999 | C | 5 | |a 10.1038/npp.2012.127 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/npp.2012.127 |
| 999 | C | 5 | |a 10.1001/jama.2009.1308 |9 -- missing cx lookup -- |2 Crossref |o 10.1001/jama.2009.1308 |
| 999 | C | 5 | |a 10.1016/j.neuroimage.2006.10.014 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neuroimage.2006.10.014 |
| 999 | C | 5 | |a 10.1001/archpsyc.64.8.932 |9 -- missing cx lookup -- |2 Crossref |o 10.1001/archpsyc.64.8.932 |
| 999 | C | 5 | |a 10.1038/376572a0 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/376572a0 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|